Media headlines about DENTSPLY SIRONA (NASDAQ:XRAY) have trended very positive this week, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than 6,000 blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. DENTSPLY SIRONA earned a media sentiment score of 3.10 on their scale. InfoTrie also assigned media coverage about the medical instruments supplier an news buzz score of 10 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company’s share price in the immediate future.
Here are some of the news stories that may have impacted DENTSPLY SIRONA’s ranking:
- DENTSPLY SIRONA (XRAY) Receives Daily News Impact Score of 3.10 (americanbankingnews.com)
- Dental Imaging Equipment Market to represent a significant expansion at 6.8% CAGR by 2024 (openpr.com)
- Global Medical X-ray Market Grow at a CAGR of 6.0% During the Forecast Period 2017-2024 (pmlive.com)
- Head to Head Analysis: Biomerica (BMRA) vs. DENTSPLY SIRONA (XRAY) (americanbankingnews.com)
Several research firms have recently commented on XRAY. Zacks Investment Research restated a “hold” rating on shares of DENTSPLY SIRONA in a research note on Saturday, November 17th. BidaskClub raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a report on Wednesday. Barclays dropped their target price on shares of DENTSPLY SIRONA from $55.00 to $41.00 and set an “equal weight” rating for the company in a report on Wednesday, August 8th. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and dropped their target price for the stock from $54.00 to $40.00 in a report on Wednesday, August 8th. Finally, HC Wainwright reaffirmed a “hold” rating and issued a $40.00 target price on shares of DENTSPLY SIRONA in a report on Wednesday, August 8th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and six have issued a buy rating to the company’s stock. DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average price target of $51.50.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 8th. The medical instruments supplier reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.08). DENTSPLY SIRONA had a positive return on equity of 8.68% and a negative net margin of 41.97%. The firm had revenue of $928.40 million during the quarter, compared to the consensus estimate of $951.58 million. During the same period in the prior year, the company posted $0.70 EPS. The company’s quarterly revenue was down 8.0% on a year-over-year basis. On average, sell-side analysts forecast that DENTSPLY SIRONA will post 1.97 EPS for the current year.
ILLEGAL ACTIVITY WARNING: This report was published by WKRB News and is owned by of WKRB News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.wkrb13.com/2018/11/24/dentsply-sirona-xray-receiving-very-positive-media-coverage-report-shows.html.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Featured Article: Insider Trading – What You Need to Know
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.